Quipt Home Medical Corp. reiterates outlook for 2022. Based on the current operations, market trends and completed and prospective acquisitions, the Company is reiterating it outlook for its annual run-rate revenue by the end of calendar 2022 (Fiscal First Quarter 2023) to be $180-$190 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.24 CAD | -1.85% | -0.47% | -37.19% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.19% | 134M | |
+17.06% | 82.59B | |
-28.48% | 69.86B | |
0.00% | 26.5B | |
+3.35% | 17.29B | |
-13.68% | 16.61B | |
+1.92% | 15.56B | |
+71.78% | 13.2B | |
+1.63% | 12.75B | |
+70.76% | 12.6B |
- Stock Market
- Equities
- QIPT Stock
- News Quipt Home Medical Corp.
- Quipt Home Medical Corp. Reiterates Outlook for 2022